RhoVac Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
RhoVac General Information
Description
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
Contact Information
Website
www.rhovac.comCorporate Office
- Medicon Village, Scheeletorget 1
- 223 63 Lund
- Sweden
Corporate Office
- Medicon Village, Scheeletorget 1
- 223 63 Lund
- Sweden
RhoVac Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RhoVac Comparisons
Industry
Financing
Details
RhoVac Competitors (5)
One of RhoVac’s 5 competitors is Cantargia, a Formerly VC-backed company based in Lund, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cantargia | Formerly VC-backed | Lund, Sweden | ||||
| BioInvent International | Formerly VC-backed | Lund, Sweden | ||||
| Atara Biotherapeutics | Formerly VC-backed | Thousand Oaks, CA | ||||
| Active Biotech | Corporation | Lund, Sweden | ||||
| Anocca | Venture Capital-Backed | Sodertalje, Sweden |
RhoVac Signals
RhoVac Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
RhoVac FAQs
-
When was RhoVac founded?
RhoVac was founded in 2007.
-
Where is RhoVac headquartered?
RhoVac is headquartered in Lund, Sweden.
-
What is the size of RhoVac?
RhoVac has 13 total employees.
-
What industry is RhoVac in?
RhoVac’s primary industry is Drug Discovery.
-
Is RhoVac a private or public company?
RhoVac is a Private company.
-
What is the current valuation of RhoVac?
The current valuation of RhoVac is .
-
What is RhoVac’s current revenue?
The current revenue for RhoVac is .
-
How much funding has RhoVac raised over time?
RhoVac has raised $2.55M.
-
Who are RhoVac’s investors?
M2 Asset Management and Swedish Growth Fund have invested in RhoVac.
-
Who are RhoVac’s competitors?
Cantargia, BioInvent International, Atara Biotherapeutics, Active Biotech, and Anocca are competitors of RhoVac.
-
When was RhoVac acquired?
RhoVac was acquired on 18-Jan-2023.
-
Who acquired RhoVac?
RhoVac was acquired by Chosa Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process